Approximately 1 in every 3 cases of COVID-19 infection recorded every day in the world is now in India, where the rate of new infections is growing faster than in any other country.
The second wave of COVID-19 infection in India has completely blocked the country’s medical infrastructure as families desperately ask for oxygen and other life-saving materials on social media.
In the capital of New Delhi morgues are used mass cremations dispose of the bodies of COVID victims. In some hospitals, patients wait outside in ambulances due to a lack of fans inside.
Volunteers are also actively helping to address supply issues, including India cares, a community of more than 3,000 people who use social media to search for everything from blood donors to oxygen and drugs.
Mohd Sakib, a 23-year-old student who recently contacted the organization, told BuzzFeed News that appeals for help are increasing day by day.
“We lose daily from our Indian family,” Satsib said. “If a person [makes a] please, and then after a while we know that the same person is no more, this moment is the worst. “
In an emergency meeting Under the chairmanship of Indian Prime Minister Narendra Modi, officials agreed to redirect oxygen destined for industrial purposes to urgent medical needs and use the country’s transport networks to deliver supplies more quickly to the states most in need.
Modi also called on states to be more proactive regarding potential stockpiling.
In the first year of the pandemic, India escaped the worst case of COVID-19. Although the nation ranks fourth in the world on its own the official world death tollfor the U.S., Brazil, and Mexico, mortality rates were low compared to a population of nearly 1.4 billion. And when India entered in 2021, the disease seemed to be under control as cases and deaths fell from a peak in September.
But since March, there has been an outbreak of infections in the country suspected of being a new variant of the coronavirus called B.1.617. The Indian National Institute of Virology has reported that this option is accepted leading position in gearappearing in about 61% of cases tested last week in one province. It is sometimes referred to as the “double mutant” variant because it contains two mutations associated with increased infection; his role in the India outbreak remains unclear due to limited medical trials for options.
Now, about one in three cases of COVID-19 infection, which is recorded every day worldwide, is in India, and the rate of new infections is growing faster than in any other country. Every day there are about 2,000 deaths related to COVID, which is about one-sixth of the world. But Financial Times analysis based on cremation records it can be assumed that many people dying from COVID-19 in India are not included in official statistics.
With the health care system balancing on the brink of collapse, Giridhar R. Babu, an epidemiologist with the Indian Public Health Foundation (PHFI), warned that “this will not be the last wave and not the last pandemic”.
In an interview with local average, Babu said that the current situation in India should be global in nature.
“If in some parts of the world disease control is neglected, every other part risks importing infections,” Babu said. “We need to rigorously and scrupulously review the situation with COVID in the country, while expanding vaccine coverage.
“Strong health guidelines and resources, including enhanced epidemiological and genomic surveillance for outbreaks of COVID-19 to detect outbreaks, should be available to establish resident systems. It is unrealistic to expect tangible benefits without a strong emphasis on strengthening the health care system, especially without strengthening recruitment and capacity building. “
The situation in India has been partly blamed on government critics, including the PHFI president, accusing The Modi administration prematurely declared victory against the virus when efforts were needed to strengthen the country’s medical infrastructure.
Instead, India’s electoral authorities announced key elections in five states the country’s cricket board has given the green light to an international game with a stadium full of spectators and a Hindu festival Kumbh Mela brought millions to Haridwar for the holy feast.
The escalation of the COVID-19 crisis in India is also very bad news for global efforts to vaccinate people against coronavirus. The Indian Serum Institute in Pune is the world’s largest vaccine manufacturer and has been challenged making an initial 200 million doses versions of the Oxford / AstraZeneca vaccine for COVAX, a collaboration between WHO, the Innovation Preparedness Coalition and Gavi, the Vaccine Alliance, which aims to provide affordable vaccines to developing countries around the world.
But the domestic spread of the vaccine in India is struggling, only 1.4% of the population is now fully vaccinated against COVID-19. In late March India has suspended export of vaccines redirect supplies of AstraZeneca vaccine to its own vaccination route.
The Indian Serum Institute also has signed the deal produce about a billion doses of the coronavirus vaccine developed by the American company Novavax once it receives approval. Thus, further pressure on the use of the national ability to produce vaccines to amplify its own failed program will have implications worldwide. India also argued that controlling exports from the U.S. of raw materials used to produce vaccines would hamper its ability to meet global demand.
The United States is also under pressure for donations about 20 million doses unused AstraZeneca vaccines that have not yet received FDA approval. AstraZeneca has said it will soon 30 million US doses ready though US agreed to send In March, 4 million doses to Canada and Mexico. Asked about the transfer of those stocks to AstraZeneca, White House COVID-19 response coordinator Jeff Zienz said Friday that the U.S. would “explore options” for delivering surplus vaccines abroad “as confidence in its own supplies increases.” He pointed to President Joe Biden A promise of $ 4 billion to COVAX in February as an indicator of the country’s support for global vaccination.
Meanwhile, the CDC is consulting with Indian health officials and offering technical assistance, said Anthony Fauci, head of the National Institute of Allergy and Infectious Diseases.
“In a difficult situation, we try to help in any way,” he said. “Obviously they need to make their people vaccinated.”